Abstract
OBJECTIVE: The relation between body weight and mortality in type II diabetic patients has not been fully elucidated. The aim of the present study was to evaluate the impact of body weight on mortality in a well-characterized type II diabetic cohort.
RESEARCH DESIGN AND METHODS: We examined a cohort of 3398 type II diabetic patients, alive on December 1986 and followed up for 10 years, to assess mortality and its causes and to investigate the relationship between body mass index (BMI) and mortality from all and specific causes. For this purpose, survival in the different quartiles of BMI was evaluated by a Cox model, controlling for sex, age, treatment, smoking, duration of diabetes, hypertension, and fasting plasma glucose. The Cox model was applied either excluding (model 1) or including (model 2) the last three variables.
RESULTS: During the 10 ys of follow-up, 1212 deaths (639 women, 573 men) occurred in the cohort under study. Since the interaction between BMI and age was statistically significant (P = 0.002), survival was studied separately in people aged <65 and ≥65 y (median age of the cohort = 65.9 y). Under 65 y, a significantly higher all-cause mortality was observed in obese patients, that is, in the IV quartile (BMI≥30.9 kg/m2; RR = 1.74; CI 95% = 1.26–2.40), in model 1. The inclusion of hypertension, duration of diabetes, and fasting plasma glucose in the model (model 2) slightly decreased the relative risk (RR = 1.52; CI 95% = 1.10–2.11). After 65 y, higher body weight was associated with a better outcome, especially in patients belonging to the IV quartile of BMI (RR = 0.74; CI 95% = 0.62–0.90).
CONCLUSIONS: In older type II diabetic patients, a moderate excess weight predicts a better survival, while obesity is a negative prognostic factor in patients younger than 65 y. In the latter patients, the effect of obesity on mortality seems to be partly mediated by hypertension, duration of diabetes, and fasting plasma glucose.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Body mass index versus surrogate measures of central adiposity as independent predictors of mortality in type 2 diabetes
Cardiovascular Diabetology Open Access 02 December 2022
-
Weight loss and mortality risk in patients with different adiposity at diagnosis of type 2 diabetes: a longitudinal cohort study
Nutrition & Diabetes Open Access 01 June 2018
-
Nonlinear association of BMI with all-cause and cardiovascular mortality in type 2 diabetes mellitus: a systematic review and meta-analysis of 414,587 participants in prospective studies
Diabetologia Open Access 25 November 2016
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Cowie CC, Harris MI . Physical and metabolic characteristics of persons with diabetes. In: Harris MI (ed). Diabetes in America . 2nd edn. National Institutes of Health: Bethesda, MD, 1995, pp 117–164 (NIH Publ. No. 95-1468).
Maggio CA, Pi-Sunyer FX . The prevention and treatment of obesity: application to type 2 diabetes. Diabetes Care 1997; 20: 1744–1766.
Wing RR, Marcus MD, Salata R, Epstein LH, Miaskiewicz S, Blair EH . Effects of very-low-calorie diet on long-term glycemic control in obese type 2 diabetic subjects. Arch Intern Med 1991; 151: 1334–1340.
Wing RR, Blair EH, Bonomi P, Marcus MD, Watonabe R, Bergman RN . Caloric restriction per se is a significant factor in improvements in glycemic control and insulin sensitivity during weight loss in obese NIDDM patients. Diabetes Care 1994; 17: 30–36.
Lean MEJ, Powrie JK, Anderson AS, Garthweite PH . Obesity, weight loss and prognosis in type 2 diabetes. Diabetes Med 1990; 7: 228–233.
Pi-Sunyer FX . Weight loss and mortality in type 2 diabetes. Diabetes Care 2000; 23: 1451–1452.
Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW . Body-mass index and mortality in a prospective cohort of US adults. N Engl J Med 1999; 341: 1097–1105.
Lee IM, Manson JE, Hennekens CH, Paffenberger RSJR . Body weight and mortality: a 27-year follow-up of middle-aged men. JAMA 1993; 270: 2823–2828.
Manson JE, Willet WC, Stampfer MJ, Colditz GA, Hunter DJ, Hankinson SE, Hennekens CH, Speizer FE . Body weight and mortality among women. N Engl J Med 1995; 333: 677–685.
Barrett-Connor E . Epidemiology, obesity and non-insulin-dependent diabetes mellitus. Am J Epidemiol 1989; 11: 172–181.
Eriksson KF, Lindgarde F . Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. Diabetologia 1991; 34: 891–898.
Kahn BB, Flier JS . Obesity and insulin resistance. J Clin Invest 2000; 106: 473–481.
Williamson DF . Weight loss and mortality in persons with type 2 diabetes mellitus: a review of the epidemiological evidence. Exp Clin Endocrinol Diabetes 1988; 106 (Suppl 2): 14–22.
Bogerdus C, Lilliola S, Mott DM, Hollenbeck C, Reaven G . Relationship between degree of obesity and in vivo insulin action in man. Am J Physiol 1985; 248: E286–E291.
Pettitt DJ, Lisse JR,, Knowler WC, Bennett PH . Mortality as a function of obesity and diabetes mellitus. Am J Epidemiol 1982; 115: 359–366.
Chaturvedi N, Fuller JH . The WHO Multinational Study Group. Mortality risk by body weight and weight change in people with NIDDM. Diabetes Care 1995; 18: 766–774.
Stevens JS, Cai J, Pamuk ER, Williamson DF, Thun MJ, Wood JL . The effect of age on the association between body-mass index and mortality. N Engl J Med 1998; 338: 1–7.
Muggeo M, Verlato G, Bonora E, Bressan F, Girotto S, Corbellini M, Gemma ML, Moghetti P, Zenere M, Cacciatori V, Zoppini G, deMarco R . The Verona Diabetes Study: a population-based survey on known diabetes mellitus prevalence and 5-year all-cause mortality. Diabetologia 1995; 38: 318–325.
Muggeo M, Verlato G, Bonora E, Ciani F, Moghetti P, Eastman R, Crepaldi G, de Marco R . Long-term instability of fasting plasma glucose predicts mortality in elderly NIDDM patients: the Verona Diabetes Study. Diabetologia 1995; 38: 672–679.
Muggeo M, Verlato G, Bonora E, Zoppini G, Corbellini M, de Marco R . Long-term instability of fasting plasma glucose, a novel predictor of cardiovascular mortality in elderly patients with non-insulin-dependent diabetes mellitus. The Verona Diabetes Study. Circulation 1997; 961: 1750–1754.
Clayton D, Hills M . Statistical models in epidemiology. Oxford Science: Oxford, UK; 1993.
de Marco R, Locatelli F, Zoppini G, Verlato G, Bonora E, Muggeo M . Cause-specific mortality in type 2 diabetes. Diabetes Care 1999; 22: 756–761.
Manson JE, Stampfer MJ, Hennekens CH, Willet WC . Body weight and longevity. JAMA 1987; 257: 353–358.
Troiano RP, Frongillo EA, Sobal J, Levitsky DA . The relationship between body weight and mortality: a quantitative analysis of combined information from existing studies. Int J Obes Relat Metab Desord 1996; 20: 63–67.
Menotti A, Descovich GC, Lanti M, Spagnolo A, Dormi A, Seccareccia F . Indexes of obesity and all-causes mortality in Italian epidemiological data. Preventive Med 1993; 22: 293–303.
Cornoni-Huntley JC, Harris TB, Everett DF, Albanes D, Micozzi MS, Miles TP, Feldman JJ . An overview of body weight of older persons, including the impact on mortality. The National Health and Nutrition Examination Survey I—epidemiological follow-up study. J Clin Epidemiol 1991; 44: 743–753.
Mattila K, Haavisto M, Rajala S . Body mass index and mortality in the elderly. Br Med J 1986; 292: 867–868.
Hillier TA, Pedula KL . Characteristics of an adult population with newly diagnosed type 2 diabetes. Diabetes Care 2001; 24: 1522–1527.
Krauss RM, Wiston M, Fletcher BJ, Grundy SM . Obesity. Impact on cardiovascular disease. Circulation 1998; 98: 1472–1476.
Stampfer MJ, Colditz GA, Willet WC, Manson JE, Rosner B, Speizer FE, Hennekens CH . Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the Nurses' Health Study. N Engl J Med 1991; 325: 756–762.
Barret-Connor E . Looking for the pony in the HERS data (Editorial). Circulation 2002; 105: 902–903.
Stevens J, Juhaeri J, Cai J . Changes in body mass index prior to baseline among participants who are ill or who die during the early years of follow-up. Am J Epidemiol 2001; 153: 946–953.
Allison DB, Faith MS, Heo M, Townsed-Butterworth D, Williamson DF . Metaanalysis of the effect of excluding early deaths on the estimated relationship between body mass index and mortality. Obesity Res 1999; 7: 342–354.
Byers T . Body weight and mortality (Editorial). N Engl J Med 1995; 333: 723–724.
Larsson B, Avrdsudd K, When L, Wilhelmsen L, Bjorntorp P, Tibblin G . Abdominal adipose tissue, obesity and risk of cardiovascular disease and death: a 13 year follow-up of participants in the study of men born in 1913. Br Med J 1984; 288: 1401–1404.
Segal KR, Dunaif A, Gutin B, Albu J, Nymen A, Pi-Sunyer FX . Body composition not body weight is related to cardiovascular disease risk factors and sex hormone levels in men. J Clin Invest 1987; 80: 1050–1055.
Williamson DF, Thompson TJ, Thun M, Flanders D, Pamuk E, Byers T . Intentional weight loss and mortality among overweight individuals with diabetes. Diabetes Care 2000; 23: 1499–1504.
Acknowledgements
This work was supported by grants from the Italian National Research Council, the Italian Ministry of University and Scientific and Technological Research, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), and Regione Veneto. The kind support of the following pharmaceutical companies is acknowledged: Astra-Zeneca, Aventis, Bayer, Fournier Pierrel Pharma, GSK, Laboratori Guidotti, Roche, Servier Italia, A. Menarini, Merck Sharp & Dohme, Pfizer Italiana, Novo Nordisk Farmaceutici, Neopharmed and Lifescan.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zoppini, G., Verlato, G., Leuzinger, C. et al. Body mass index and the risk of mortality in type II diabetic patients from Verona. Int J Obes 27, 281–285 (2003). https://doi.org/10.1038/sj.ijo.802199
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijo.802199
Keywords
This article is cited by
-
Body mass index versus surrogate measures of central adiposity as independent predictors of mortality in type 2 diabetes
Cardiovascular Diabetology (2022)
-
Early mortality and cardiovascular disease, varied association with body mass index and its changes in insulin-treated diabetes: a nationwide study
International Journal of Obesity (2021)
-
The obesity paradox and diabetes
Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity (2021)
-
Weight loss and mortality risk in patients with different adiposity at diagnosis of type 2 diabetes: a longitudinal cohort study
Nutrition & Diabetes (2018)
-
Body mass index and the all-cause mortality rate in patients with type 2 diabetes mellitus
Acta Diabetologica (2018)